As inhibition of TLR4, CXCR4 and CCR7 impacted anti-tumor immunity and reduced tumorigenesis (tumor numbers, growth and metastasis) (17, 18, 45), our novel OSCC13 grafting model may be suitable to investigate these and other alternative targeting approaches in particular in combination with radiotherapy. This evidence concerns the gene CXCR4 and neoplasm.